These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8418831)

  • 1. Characterization of purified recombinant fibrinogen: partial phosphorylation of fibrinopeptide A.
    Binnie CG; Hettasch JM; Strickland E; Lord ST
    Biochemistry; 1993 Jan; 32(1):107-13. PubMed ID: 8418831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.
    Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST
    Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy for recombinant multichain protein synthesis: fibrinogen B beta-chain variants as thrombin substrates.
    Lord ST; Strickland E; Jayjock E
    Biochemistry; 1996 Feb; 35(7):2342-8. PubMed ID: 8652575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
    Rooney MM; Mullin JL; Lord ST
    Biochemistry; 1998 Sep; 37(39):13704-9. PubMed ID: 9753458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
    Soya K; Terasawa F; Okumura N
    Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen Barcelona I. Congenital dysfibrinogenemia characterized by defective release of fibrinopeptide A and fibrinogen degradation products.
    Vila V; Regañón E; Aznar J; Navarro G; Salas M
    Thromb Res; 1987 Mar; 45(5):437-49. PubMed ID: 2954261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of structures of various human fibrinogens and a derivative thereof by a study of the kinetics of release of fibrinopeptides.
    Hanna LS; Scheraga HA; Francis CW; Marder VJ
    Biochemistry; 1984 Sep; 23(20):4681-7. PubMed ID: 6238619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased phosphorylation of human fibrinopeptide A under acute phase conditions.
    Seydewitz HH; Witt I
    Thromb Res; 1985 Oct; 40(1):29-39. PubMed ID: 4089825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased plasmin resistance by clots of a homophenotypic Aalpha R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release).
    Galanakis DK; Neerman-Arbez M; Kudryk B; Henschen A
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):135-9. PubMed ID: 20019599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant fibrinogen studies reveal that thrombin specificity dictates order of fibrinopeptide release.
    Mullin JL; Gorkun OV; Binnie CG; Lord ST
    J Biol Chem; 2000 Aug; 275(33):25239-46. PubMed ID: 10837485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
    Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
    J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of engineered fibrinogen variants suggests that an additional site mediates platelet aggregation and that "B-b" interactions have a role in protofibril formation.
    Lounes KC; Ping L; Gorkun OV; Lord ST
    Biochemistry; 2002 Apr; 41(16):5291-9. PubMed ID: 11955079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The conversion of fibrinogen to fibrin: recombinant fibrinogen typifies plasma fibrinogen.
    Gorkun OV; Veklich YI; Weisel JW; Lord ST
    Blood; 1997 Jun; 89(12):4407-14. PubMed ID: 9192765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin-induced fibrinopeptide release from a fibrinogen variant (fibrinogen Sydney I) with an Aalpha Arg-16----His substitution.
    Southan C; Lane DA; Bode W; Henschen A
    Eur J Biochem; 1985 Mar; 147(3):593-600. PubMed ID: 3979390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An engineered fibrinogen variant AαQ328,366P does not polymerise normally, but retains the ability to form α cross-links.
    Park R; Ping L; Song J; Seo JY; Choi TY; Choi JR; Gorkun OV; Lord ST
    Thromb Haemost; 2013 Feb; 109(2):199-206. PubMed ID: 23224113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of A alpha 251 fibrinogen: the alpha C domain has a role in polymerization, albeit more subtle than anticipated from the analogous proteolytic fragment X.
    Gorkun OV; Henschen-Edman AH; Ping LF; Lord ST
    Biochemistry; 1998 Nov; 37(44):15434-41. PubMed ID: 9799505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.
    Goodwin CA; Kakkar VV; Scully MF
    Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):613-8. PubMed ID: 1531588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight from studies with recombinant fibrinogens.
    Lord ST; Gorkun OV
    Ann N Y Acad Sci; 2001; 936():101-16. PubMed ID: 11460465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant γY278H Fibrinogen Showed Normal Secretion from CHO Cells, but a Corresponding Heterozygous Patient Showed Hypofibrinogenemia.
    Kamijo T; Kaido T; Yoda M; Arai S; Yamauchi K; Okumura N
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.